arrow
P

Pamela Minicozzi

Fondazione IRCCS Istituto Nazionale dei Tumori
H指数:43
被引数:7,034

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer

基于昼夜节律的预后模型用于切除的I期非小细胞肺癌

Cancers
IF4.4
2026-10-050
OA
Radiation therapy and overall survival in male breast cancer: a multicenter analysis of 302 patients

放射治疗与男性乳腺癌患者总生存期:一项对302例患者的多中心分析

2026-09-280
PRE
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy

HER2-low乳腺癌是免疫冷型肿瘤:肿瘤浸润免疫细胞的见解及其对免疫治疗的启示

2025-12-030
OAAI
Global variation in patterns of care and time to initial treatment for breast, cervical, and ovarian cancer from 2015 to 2018 (VENUSCANCER): a secondary analysis of individual records for 275 792 women from 103 population-based cancer registries in 39 countries and territories

2015年至2018年全球范围内乳腺癌、宫颈癌和卵巢癌的护理模式及初始治疗时间差异(VENUSCANCER):一项基于39个国家和地区103个基于人群的癌症登记处275,792名女性个体记录的二次分析

2025-10-220
OAAI
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)
2022-11-1020
OAAI
Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries
2022-06-0138
OAAI
Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)
2020-09-017
OAAI
Comorbidities, timing of treatments, and chemotherapy use influence outcomes in stage III colon cancer: A population-based European study

合并症,治疗时机和化疗使用影响III期结肠癌的结局: 一项基于人群的欧洲研究

EJSO
IF2.9
2020-06-0110
PREAI
Bratislava Statement: consensus recommendations for improving pancreatic cancer care
2020-01-0112
OAAI